Literature DB >> 31975752

Key Features of Insulin Delivery Devices for Type 2 Diabetes: Type 2.0 Booth Survey.

David Sze1, Teresa Oliveria1.   

Abstract

This article reports on a survey conducted at four diabetes-related annual conferences in 2017 and 2018 to obtain input from the medical community regarding the most important features of insulin delivery devices to address the unmet needs of people with type 2 diabetes who require basal/bolus insulin therapy. The overall patterns of responses compiled from 742 participating health care providers, each voting for three of eight proposed features of insulin delivery devices, were mostly similar numerically at each conference. The features garnering the top three percentages of votes (n = 2,226) averaged for all four conferences were tube-free patch (14.7%), reduced number of insulin injections (14.7%), and dose capture report (14.2%). Four other features received almost as many votes: flexible dosing (14.0%), patient lifestyle app (13.3%), wireless controller (12.7%), and interconnected glucose monitoring (12.6%). This survey provided valuable information that can aid the development of future insulin delivery devices.
© 2019 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 31975752      PMCID: PMC6969661          DOI: 10.2337/cd19-0014

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  22 in total

1.  Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study.

Authors:  M Peyrot; A H Barnett; L F Meneghini; P-M Schumm-Draeger
Journal:  Diabetes Obes Metab       Date:  2012-07-17       Impact factor: 6.577

2.  CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN.

Authors:  Rosemarie Lajara; Jaime A Davidson; Carla C Nikkel; Tracy L Morris
Journal:  Endocr Pract       Date:  2016-02-01       Impact factor: 3.443

3.  Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.

Authors:  Kasia J Lipska; Irl B Hirsch; Matthew C Riddle
Journal:  JAMA       Date:  2017-07-04       Impact factor: 56.272

Review 4.  Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.

Authors:  John C Pickup; Yves Reznik; Alex J Sutton
Journal:  Diabetes Care       Date:  2017-05       Impact factor: 19.112

Review 5.  6. Glycemic Targets: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

6.  Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.

Authors:  William H Polonsky; Lawrence Fisher; Danielle Hessler; Steven V Edelman
Journal:  Diabetes Technol Ther       Date:  2015-07-13       Impact factor: 6.118

7.  A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes.

Authors:  Julia K Mader; Leslie C Lilly; Felix Aberer; Stefan Korsatko; Ellie Strock; Roger S Mazze; Peter Damsbo; Thomas R Pieber
Journal:  Diabetes Care       Date:  2014-03-05       Impact factor: 19.112

8.  Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System.

Authors:  Rosemarie Lajara; Dianne A Fetchick; Tracy L Morris; Carla Nikkel
Journal:  Diabetes Ther       Date:  2015-10-15       Impact factor: 2.945

9.  Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device).

Authors:  Meryl Brod; Mette Hammer; Torsten Christensen; Suzanne Lessard; Donald M Bushnell
Journal:  Health Qual Life Outcomes       Date:  2009-09-09       Impact factor: 3.186

10.  Standards of Medical Care in Diabetes-2019 Abridged for Primary Care Providers.

Authors: 
Journal:  Clin Diabetes       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.